OBJECTIVES: This study aims to assess the impact of morphological type on the prognosis of obstructive hypertrophic cardiomyopathy patients who underwent myectomy.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is characterized by a substantial genetic and phenotypic heterogeneity, leading to considerable diversity in the clinical course [1] . Traditionally, 2D echocardiography has been the most reliable and widely used method for clinical diagnosis of HCM. Based on the conventional echocardiography reports, surgeons know only the maximal thickness of the left ventricle and the dimension and function of the left ventricle, but a resection strategy still requires perioperative transoesophageal echocardiography or intraoperative palpation. Cardiovascular magnetic resonance (CMR), with its high spatial resolution and tomographic imaging capabilities, has emerged as a technique particularly well-suited to characterize the diverse phenotypic expression of this complex disease. In patients with good echocardiographic images, CMR cannot provide more information on ventricular function and morphology [2] , but it is helpful in establishing a diagnosis of HCM in patients with poor acoustic windows [3] and identifying areas of segmental hypertrophy not reliably visualized by echocardiography [1] . Different morphological types of HCM have been reported, and it is usually classified by the hypertrophy morphology sites including basal, midventricular and apical hypertrophies [4, 5] . Invasive septal myectomy has been established as the standard treatment for HCM patients refractory to medicinal intervention. Multiple studies have reported excellent outcomes following surgical myectomy for the relief of left ventricular outflow tract †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-10 October 2017.
(LVOT) obstruction in HCM patients with [6] [7] [8] [9] or without concomitant surgery [10, 11] . Surgical myectomy may alter the natural course of HCM and give most patients a lifespan similar to an age-matched population [9, 10, 12] . However, none of those studies compared the prognosis of HCM patients with different morphological types of left ventricle following surgical myectomy, possibly because of lack of comprehensive CMR evaluations. This study aims to investigate the impact of morphological subtypes on clinical outcome in HCM patients who underwent surgical myectomy.
MATERIALS AND METHODS

Population
We reviewed electronic medical records of symptomatic obstructive HCM adult patients refractory to medicinal treatment who underwent surgical myectomy at the Fuwai Hospital consecutively from June 2011 to April 2016. The diagnosis of HCM was based on the echocardiography detection of ventricular septum (VS) hypertrophy (maximal septum thickness >15 mm), without another cardiac or systemic cause according to the current guidelines [13] . We performed surgical myectomy for obstructive HCM in 706 patients during the study period. The following inclusion criteria were applied: (i) >18 years at the time of surgery, (ii) no presence of more-than-mild aortic or mitral stenosis and (iii) without hypertensive heart disease and LVOT obstruction [8] . Preoperative CMR failed to be performed in all patients due to long waiting times for scheduling the CMR appointment. To evaluate the prognostic significance of the morphological type of hypertrophy, we excluded 234 patients without CMR. Furthermore, 3 patients with classic apex hypertrophy and concomitant LVOT obstruction has also been excluded. Finally, 469 eligible patients were included in this study. All patients were divided into 3 groups by the LV morphological type based on CMR imaging and referring to previous reports [5, 14] : (i) the basal group, hypertrophy limited to the basal septum, sparing the middle and apical segments of the VS and free wall; (ii) the septum group, hypertrophy of the whole VS (mainly middle segment of the VS) without the LV free wall involved [4] and (iii) the LV group, diffuse hypertrophy of the whole left ventricle including the VS and free wall. The ethics committee of the Fuwai Hospital approved this research.
Echocardiography
Echocardiography was preoperatively performed in all patients with the use of a commercially available instrument. LV ejection fraction and maximal chamber dimensions including the left atrial diameter and end-diastolic LV wall thickness were measured according to the standard protocol [15] . Resting LVOT pressure gradient was estimated through resting LVOT peak velocity by using a simplified Bernoulli equation. Exercise echocardiography was further applied to assess the maximal LVOT gradients in patients with resting LVOT gradients <50 mmHg. In addition, all patients underwent an echocardiogram in a manner similar to preoperative assessment before discharge and 3 months and 1 year after surgery.
Cardiac magnetic resonance imaging
CMR was performed on a 1.5-T magnetic resonance scanner (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany).
All imaging acquisitions were captured under breath control. True imaging with steady-stage precession sequence (TrueFISP) was chosen for cine scans in multiple short-axis and 3 long-axes views (2-chamber, 4-chamber and LVOT). Late gadolinium enhancement (LGE) images were acquired 15 min after intravenous administration of 0.2 mmol/kg gadolinium-DTPA (Magnevist, Schering, Berlin, Germany) using a phase-sensitive inversion recovery-spoiled gradient echo sequence. LGE images were obtained on a standard short-axis covering the whole ventricle and in long-axis views. CMR image analysis (including the LV wall mass and left atrial volume) we performed on a commercial imaging workstation (Siemens Medical Systems).
Cardiac surgery
As described in our previous report [16] , we applied extended septal myectomy evolving from the classic Morrow procedure. The hypertrophic VS leading to systolic anterior motion of the anterior mitral valve and LVOT obstruction was resected. The resection range in the long-axis direction started from approximately 4 mm below the aortic ring to the apex of the left ventricle beyond the bases of the papillary muscles. In the shortaxis direction, the myectomy started rightward to the nadir of the right aortic cusp and to the left and terminated near the mitral anterior commissure [16] . Part of the LV anterior free wall detached to the VS causing LVOT narrowing may also need to be resected. Furthermore, the anomalous chordal attachments between the mitral valve leaflets or papillary muscle and the VS were also excised. Additional surgery was performed based on expert consensus among the experienced cardiac surgeons. If intraoperative transoesophageal echocardiography detected a postoperative LVOT gradient >30 mmHg or more-than-moderate mitral valve regurgitation after weaning from cardiopulmonary bypass, reoperation was required.
Follow-up and outcomes
Clinical status was obtained through phone conversation with patients or family members every year after myectomy. The last follow-up was conducted from April to May 2017. Survival analysis included the analysis of cardiovascular mortality, major cardiovascular events and composite cardiovascular events. The primary end-point (cardiovascular mortality) was cardiovascular death including sudden cardiac death (SCD), resuscitation from SCD, congestive heart failure-related death and stroke-related death. The secondary end-point (non-fatal cardiovascular event) was a composite of stroke, embolism and congestive heart failure requiring hospitalization or a subsequent cardiac surgical procedure [6] . Composite cardiovascular events included the primary end-point and secondary end-point events. Patients lost to follow-up were censored at the last follow-up.
Statistical analyses
Continuous variables were presented as the mean ± standard deviation or the median (interquartile range). One-way analysis of variance was used to compare continuous variables between groups, and the Student-Newman-Keul test was further applied for post hoc multiple comparisons. The Kruskal 
RESULTS
Pattern and distribution of left ventricular hypertrophy
The most common location for increased LV wall thickness in obstructive HCM patients was the basal septum ( Fig. 1A) (n = 248; 52.9%). In 141 (30.1%) of the 469 study patients, hypertrophy involved the whole VS (mainly midventricular) but spared the LV free wall (Fig. 1B) . In 80 (17.1%) of the 467 HCM study patients, CMR identified hypertrophy involving the whole left ventricle, including the VS, both anterior and posterior LV free wall (Fig. 1C) .
Baseline characteristics and outcome between different types of left ventricular hypertrophy
Clinical and demographic characteristics of the 469 study patients are summarized in Table 1 . The ratio of male gender in the basal group was lower than the other 2 groups, and the patients in the basal group were older. There was no difference among groups in the New York Heart Association (NYHA) functional class. The ratio of preoperative AF in the basal group tended to be higher than the other 2 groups, but there was no statistical significance. Compared to patients with basal hypertrophy, the ratio of maximal wall thickness >30 mm and being extensive LGE positive in the septum and LV groups was also higher. The LV mass, maximal resting LVOT gradients and left atrial diameter in the LV group were higher than in the other 2 groups (P < 0.05), which may be ascribed to serious hypertrophy leading to severe LVOT obstruction and subsequent LA remodelling. However, patients with basal hypertrophy tended to have larger left atrial volume, which can reflect LA remodelling more accurately. As expected, the LV mass in the septum group was higher than in the basal group but lower than in the LV group. Table 2 presents intraoperative data and postoperative outcomes among the 3 types of LV hypertrophy. To thoroughly eliminate the LVOT obstruction, the resection of the VS extended to the apex of the left ventricle beyond the bases of papillary muscles. Because the hypertrophy was limited to the basal segment of the VS in the basal group, the aortic clamp time reflecting the complications of myectomy was lower than that in the LV group (Table 2) . However, the length of postoperative inhospitalization stay and residual LVOT gradients (>30 mmHg) were not significantly different among the 3 groups (Table 2) .
Survival comparisons between different subtypes of left ventricular hypertrophy
Only 1 (0.21%) patient died due to severe septic shock in the early postoperative period. Two (0.43%) patients had undergone reoperation for bleeding, while 3 patients (0.64%) had wound infection. Iatrogenic ventricular septal defect was detected and immediately repaired in 4 (0.81%) patients, while 11 (2.34%) patients required permanent pacemaker implantations postoperatively.
The only 1 perioperative death and 1 death attributable to lung cancer (non-cardiac death) were excluded from the survival analysis. Four patients were lost to the last follow-up and were censored in the survival analysis. During the mean 2.5 ± 1.4 years of follow-up, 10 of the 467 study patients (2.14%; 0.85% per year) met the primary end-point of cardiovascular death in this cohort. Only 1 patient who had limited basal VS hypertrophy met the primary end-point event, while 4 patients with whole septum hypertrophy and 5 patients with hypertrophy of the whole left ventricle met the primary end-point. There was a significant difference in the survival analysis between different subtypes of LV hypertrophy after surgical myectomy in obstructive HCM patients (Fig. 2) . Compared with basal hypertrophy patients, segmental hypertrophy confined to the basal anterior septum, sparing the middle and apical segment of the ventricular septum and free wall, representing the most common types of LV hypertrophy in obstructive hypertrophic cardiomyopathy; (B) the septum group: involving the whole ventricular septum (mainly the middle segment of the septum), but sparing the LV free wall and (C) the LV group: hypertrophy involving the whole left ventricle including the whole septum and LV free wall.
patients with hypertrophy of the whole septum were not significantly different (P = 0.059), but patients with hypertrophy of the whole left ventricle showed a statistically distinguishable lower survival rate free from the primary end-point events (P = 0.001).
No difference was observed in survival free from the primary end-point between the septum and LV groups (P = 0.18).
The analysis was further focused on the secondary end-point events to evaluate the impact of morphological types on nonfatal cardiovascular events. The survival rate free from secondary end-point events in the LV group tended to be higher, but the difference was not statistically significant (Fig. 3A) . Furthermore, in terms of composite cardiovascular events, no difference was observed (Fig. 3B) .
DISCUSSION
Because of its unique strengths that make it particularly well-suited to provide detailed characterization of the HCM phenotype, CMR has become an important imaging technique for HCM patients [1, 5, [17] [18] [19] . Most previous reports of invasive myectomy in HCM lacked CMR data. Practically, 2D echocardiography is more Values are presented as the mean 6 SD, median (IQR) or n (%). *P < 0.05: versus basal group. feasible and less complicated than CMR, and so it is widely applied for the diagnosis and surgical planning of HCM. If the surgeon does not review the 2D echocardiography personally, he or she cannot create a detailed surgical planning based on the subjective and limited data offered by the sonographer. Furthermore, the presence of massive hypertrophy alone fails to reflect the morphology of the left ventricle. The patterns of LV hypertrophy may also be meaningful [5] . It is unclear whether the site of massive hypertrophy may also impact on the prognosis just as the maximal thickness does. Therefore, comprehensive assessment of maximal wall thickness and patterns of LV hypertrophy is an essential part of the initial evaluation of all HCM patients. CMR can provide 3D tomographic imaging with high spatial and temporal resolution images of the heart in any plane [19] . In our centre, CMR was not routinely performed preoperatively until 2014 when we learned of the morphological diversity of ventricular hypertrophy and papillary muscles as well as the importance of preoperative resection planning. CMR made it possible to compare prognostic characterization in HCM patients with the diverse phenotypic expressions. Overall, the prevalence of LV hypertrophy was similar to previous studies [5] . However, there were slight differences because all patients in this study had serious LVOT obstruction. Several clinical and demographic characteristics of patients in the 3 groups were different. The patients with hypertrophy of the whole left ventricle were younger, which may ascribe to the serious hypertrophy leading to serious symptoms requiring early invasive intervention. Compared with basal segment hypertrophy, other regions of the left ventricle have also been involved in the septum and LV groups. Diffuse hypertrophy may lead to severe LVOT obstruction and subsequent LA enlargement. As shown in this study, the LV mass, maximal resting LVOT gradients and left atrial diameter in the LV group were higher than the other groups. Maximal LV wall thickness was regarded as an important risk factor for SCD [20, 21] . Increased LV mass and LGE presentation were not regularly incorporated into the assessment of SCD risk stratification, although both increased LV mass and LGE were reported to be associated with worse outcomes in HCM patients [22] [23] [24] . This study showed that whole septum or LV hypertrophy might be another underlying indicator of SCD risk with increased LV mass, higher ratio of extensive LGE and maximal thickness >30 mm.
Although there was no difference in the length of postoperative in-hospitalization stay and relief of LVOT obstruction among the 3 groups, the survival rate free from cardiac death after surgical myectomy was different. In line with previous studies, surgical myectomy may reduce the SCD risk [25] and alter the natural course of HCM [9, 10, 12] . Myectomy nearly eliminated the SCD risk in the basal group, while it did not abolish SCD in patients with whole septum or LV hypertrophy. The Morrow procedure primarily aims to eliminate the LVOT obstruction by resecting the abnormal hypertrophic myocardium. This intervention may be sufficient for patients in the basal group resulting in morphology similar to the normal population but not sufficient for other HCM patients. For patients with whole septum or LV hypertrophy, a modified Morrow procedure extending to the bases of the papillary muscles may be indispensable. This fact may explain the reason why extended Morrow procedure showed better clinical prognosis. Furthermore, to avoid injury of the conduction bundle, the incision usually cannot extend Cumulative survival curve free from the secondary and composite end-points between the 3 hypertrophic subtypes of hypertrophic cardiomyopathy patients who underwent invasive myectomy. In terms of postoperative survival free from the secondary and composite end-points, there was no difference among the 3 different morphological types of left ventricular hypertrophy. The basal group with limited basal hypertrophy (n = 248), the septum group with whole ventricular septum hypertrophy (n = 141) and the LV group with hypertrophy of the whole left ventricle (n = 80). Overall log-rank, P = 0.14 (A) and P = 0.91 (B).
rightward beyond the middle of the right coronary sinus at the base of the left ventricle. Residual SCD in patients in the septum and LV groups may be attributable to the lack of change in the hypertrophy of the posterior VS and free wall after myectomy.
HCM is a disease of the myocytes, the pathophysiology of which does not change after surgical resection [1] . Residual abnormal myocardium may also lead to SCD, even if the LVOT obstruction was relieved. It was reported that increased LV mass indicated poor prognosis in HCM patients [22] . In this cohort, the LV mass and ratio of extensive LGE in the basal group were lower than the other 2 groups. Invasive myectomy resected the abnormal hypertrophic myocardium in the anterior basal VS, resulting in 'normalization' of the LV morphology in patients with basal hypertrophy. However, the abnormal hypertrophy of the posterior VS and the free LV wall in the septum and LV groups still existed, which may be the underlying reason as to why patients in the LV group had worse clinical outcomes.
The survival rate free from secondary end-point events (nonfatal cardiovascular events) of patients with the basal septum hypertrophy tended to be lower, but the difference was not statistically significant among groups. This result may be ascribed to patients in the basal group being older and having a slightly higher incidence of preoperative atrial fibrillation [6, 8] . Furthermore, no difference in the composite event-free survival between different morphological types existed.
Limitations
This retrospective study has several limitations. First, patients who did not undergo CMR have been excluded, leading to unintentional selection bias. However, only certain baseline parameters were slightly different between patients with or without CMR. Second, most of the patients declined implantable cardioverterdefibrillator implantation. None of the patients underwent implantable cardioverter-defibrillator implantation preoperatively, while only 1 patient accepted implantable cardioverter-defibrillator implantation postoperatively after revival from SCD.
CONCLUSION
In conclusion, patient with different morphological types of ventricular hypertrophy did not show the same prognosis after invasive myectomy. Patients with hypertrophy limited to the basal VS showed a better prognosis. Diffuse hypertrophy of the VS and free wall indicated lower survival after surgical myectomy.
